SHIFT Newsroom · GLOBAL
Knee replacement: GLP-1 use associated with fewer infections
This matched retrospective analysis found an association between GLP-1 receptor agonist use and lower periprosthetic joint-infection risk after knee replacement. It does not prove that the medicines prevent infection. Findings for other surgical outcomes differed.
What the source says
This matched retrospective analysis found an association between GLP-1 receptor agonist use and lower periprosthetic joint-infection risk after knee replacement. It does not prove that the medicines prevent infection. Findings for other surgical outcomes differed.
Evidence and limits
Researchers matched users and non-users and compared complications over two years after knee replacement. Lower infection rates were associated with GLP-1 use, while differences in mechanical outcomes were not statistically significant. This does not prove infection prevention.
What we checked
We checked the primary publication record and available abstract. The full paper and supplements have not been reviewed for this correction.
SHIFT’s take
For someone with sore knees, these findings are research context rather than a promise about surgery. Discuss medicines and surgery with the prescribing and surgical teams.
Known facts
- This matched retrospective analysis found an association between GLP-1 receptor agonist use and lower periprosthetic joint-infection risk after knee replacement.